Researchers have discovered an experimental medication that significantly reduces a cholesterol-like particle that can ...

Two novel agents targeting angiopoietin-like protein 3 demonstrated safety and lipid-lowering capabilities in phase 2 trials, ...

Topiramate, also sold under the brand name Topamax, is a drug approved by the U.S. Food and Drug Administration (FDA) for ...

Visit-to-visit variability in lipid levels is associated with an increased risk for heart failure in patients with T2D, ...

High levels of a chemical that is believed to be behind sudden and inexplicable heart attacks and strokes could soon have multiple drugs to treat it ...

Deciding whether to start hormone therapy during the menopause transition, the life phase that's the bookend to puberty and ...

A recent study shows that traditional insulin resistance measures such as HOMA-IR are more predictive of insulin resistance ...

Metabolic syndrome is linked to greater risk of developing young-onset dementia, according to a new study. But there are ...

Oral hormone therapy may benefit heart health in menopausal women. A new analysis of data from the Women's Health Initiative found that estrogen-based oral hormone therapy had a long-term beneficial ...

Elevated lipoprotein(a) concentrations are associated with atherosclerotic cardiovascular disease. The safety and efficacy of lepodisiran, an extended-duration, small interfering RNA targeting ...